logo
AI in Healthcare Faces Growing Skepticism Among Patients

AI in Healthcare Faces Growing Skepticism Among Patients

Medscape21-05-2025

This transcript has been edited for clarity.
Hello. I'm Dr Markman, from City of Hope. I'd like to briefly discuss two separate but related articles that recently appeared, which touch on the evolving and critically important topic of artificial intelligence.
The first paper is 'Patients' Trust in Health Systems to Use Artificial Intelligence.'The second paper is 'Public Attitudes Toward Notification of Use of Artificial Intelligence in Health Care.' Both of these manuscripts were published in JAMA Network Open .
In both cases, the studies were surveys of US adults from the National Opinion Research Center. The first study was from June to July 2023. There were 2039 respondents (51% female) and very reasonable representation based upon various ethnic subgroups.
The general trust in the healthcare system was asked of this group. On a scale of 0 to 12, the mean score was 5.38. This is already telling you that perhaps there may be a bit of a concern here.
Now, turning to the question that we're highlighting here, which is about trust in the system to use AI responsibly. I'm going to say this and repeat it: 65.8% had low levels of trust in the healthcare system to use AI responsibly — 65.8%. Two out of three patients said they had low levels of trust in the system to use AI responsibly. This is, in my opinion, a really serious statement about how the public is viewing the situation.
Furthermore, 57.7% had low levels of trust in their healthcare system to be sure that AI would not harm them — more than half said they had a low level of trust that their system would make sure that AI would not harm them. This isvery concerning.
In the second study, there were 2021 respondents; a slight majority, 52%, were female. There was a statement posed: 'It is important that I am notified about the use of AI in my healthcare.' The question was, "How important is that statement?" and 62.7% of respondents said — and this is the highest level — it was very true that they wanted to be notified if AI was being used in their healthcare. Only 4.8%, or 1 out of 20 patients, said they didn't want to be notified.
Clearly, patients want to know it's being used and they don't want it to be used without their knowledge. Second, they are fearful and concerned. I think all members of the healthcare environment, including doctors, nurses, healthcare administrators, and payers, need to listen to this.
The public is concerned, based upon what they've read, what they've heard, podcasts they've listened to, and social media. They're concerned about the potential risk of harm, and they don't necessarily trust their own healthcare system to do what's best for them.
It's a critical message that needs to be heard. I actually agree with the opinion of the majority of the public about that potential concern.
Thank you for your attention.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Measles vaccination rates drop after COVID-19 pandemic in counties across the US
Measles vaccination rates drop after COVID-19 pandemic in counties across the US

Washington Post

time24 minutes ago

  • Washington Post

Measles vaccination rates drop after COVID-19 pandemic in counties across the US

Childhood vaccination rates against measles fell in the years after the COVID-19 pandemic in nearly 80% of the more than 2,000 U.S. counties with available data — including in states that are battling outbreaks this year. A Johns Hopkins University study, published in JAMA this week , illustrates where more vulnerable communities are located. The results mirror trends established at state and national levels : Routine childhood vaccination rates are dropping.

Pennsylvania sues U.S. Department of Agriculture over cutting funding to $1 billion food aid program for states
Pennsylvania sues U.S. Department of Agriculture over cutting funding to $1 billion food aid program for states

CBS News

timean hour ago

  • CBS News

Pennsylvania sues U.S. Department of Agriculture over cutting funding to $1 billion food aid program for states

Pennsylvania sued the U.S. Department of Agriculture on Wednesday, saying the agency, under President Donald Trump, had illegally cut off funding to it through a program designed to distribute more than $1 billion in aid to states to purchase food from farms for schools, child care centers, and food banks. The lawsuit in federal court, announced by Gov. Josh Shapiro, a Democrat, comes three months after the USDA advised states that it was ending the pandemic-era assistance program because it no longer reflected agency priorities. "I don't get what the hell their priorities are if not feeding people and taking care of our farmers," Shapiro said at a news conference at a food bank warehouse in Philadelphia. The USDA declined to comment Wednesday. The lawsuit, filed in federal court in Harrisburg, asks the court to reverse the USDA's decision to end the reimbursement program. Shapiro's administration, in the lawsuit, said the USDA's termination of the contract was illegal, saying the USDA didn't explain why it no longer reflected agency priorities and that the contract didn't expressly allow the USDA to terminate it for those reasons. Shapiro said he was confident that Pennsylvania would win the lawsuit. "A deal is a deal," Shapiro told the news conference. "They made a deal with our farmers ... they made a deal with Pennsylvania and they illegally broke it." The loss to Pennsylvania is $13 million under a three-year contract, money that the state planned to use to buy food from farms to stock food banks. States also use the money to buy food from farms for school nutrition programs and child care centers. Purchases include commodities such as cheese, eggs, meat, fruits and vegetables. The department, under then-President Joe Biden, announced a second round of funding through the program last year.

Drunk Elephant's Latest Product Offering Addresses ‘Concerns That We Heard From Our Customers': ‘Felt Like A Natural Next Step'
Drunk Elephant's Latest Product Offering Addresses ‘Concerns That We Heard From Our Customers': ‘Felt Like A Natural Next Step'

Forbes

time2 hours ago

  • Forbes

Drunk Elephant's Latest Product Offering Addresses ‘Concerns That We Heard From Our Customers': ‘Felt Like A Natural Next Step'

Drunk Elephant's Plump-C Tripeptide Lippe Mask is available to shop June 10. Drunk Elephant's latest product offering sees the company enter a category it hasn't expanded upon in a decade—lips. The brand's new Plump-C Tripeptide Lippe Mask launches June 10, making it only the second lip product in the Drunk Elephant arsenal. The mask—which the company calls 'a restorative anytime treatment to moisturize, plump and protect lips'—follows the Drunk Elephant Lippe Balm in terms of products targeting lips. The Lippe Mask is only the brand's second product offering targeting lips. 'If there's one thing I can't stand, it's dry, chapped lips, so the one thing that's always in my bag or my pocket is Lippe,' founder Tiffany Masterson wrote in a note accompanying the new product. 'As much as I love it, I wanted something that addressed deepening lip lines, uneven texture and chronic dryness on the lips. That's how Plump-C Tripeptide Lippe Mask was born.' Masterston continued that 'Plump-C is the longest-lasting moisture I've ever tried,' adding that it's clinically proven to smooth lines, even out texture and leave lips 'feeling deeply moisturized and plumper.' 'It's real lip service,' she concluded. Tiffany Masterson attends the Drunk Elephant House Of Drunk pop-up on June 10, 2019 in New York ... More City. (Photo byfor Drunk Elephant) The Lippe Mask can be used morning, night or as often as needed, the company advised. Speaking to me exclusively, Drunk Elephant's vice president of research and product development Nathan Rivas says that the new product 'is a richer version of Lippe Balm that plumps and restores.' Lippe Balm, he tells me, can be used for daily lip care, with the Lippe Mask stepping in 'as an anytime restorative treatment' when looking to firm and moisturize dry, flaky lips, 'making them softer, smoother and plumper-looking.' 'We're constantly questioning what's possible—as well as what's missing—and that's where some of the most interesting formula directions come from,' Rivas says. The company said the product can be used morning, night or whenever needed. The new product launch comes after a difficult 2024 for Drunk Elephant. In creating the Lippe Mask, the company 'answered concerns that we heard from our customers,' Rivas says, specifically in the areas of lip lines, loss of lip volume and 'a need for more intensive degree of moisture.' He calls the Lippe Mask 'an evolution in Lippe Balm.' 'We pushed to answer those concerns while also challenging the limits of what this type of formula could do for lips, including actives that aren't typical for lip masks,' he tells me. 'Vitamin C and peptides, for example, are both preventative—helping to defend skin against free radicals and preserve healthy collagen—and a treatment, as they help improve concerns like firmness and elasticity.' The Lippe Mask follows the Lippe Balm in Drunk Elephant's lip product offerings and comes a decade ... More after the Lippe Balm first came to market. 'Lippe Mask felt like a natural next step, as our best formulas are those that happen based on filling a consumer need,' Rivas tells me. 'The OG Lippe Balm is a staple for sure, though when your lips really want for more—to restore dry, flaky lips with deeper moisture—it doesn't quite meet those needs. That's how Lippe Mask was born.' The Lippe Mask retails for $28 will be available at Sephora and Ulta—as well as both retailers' websites—as well as beginning Tuesday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store